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Abstract
The splicing of the N exon in the pre-mRNA coding for the RE1-silencing transcription factor (REST) results in a truncated
protein that modifies the expression pattern of some of its target genes. A weak 3’ss, three alternative 5’ss (N4-, N50-, and
N62-5’ss) and a variety of putative target sites for splicing regulatory proteins are found around the N exon; two GGGG
codes (G2-G3) and a poly-Uridine tract (N-PU) are found in front of the N50-5’ss. In this work we analyzed some of the
regulatory factors and elements involved in the preferred selection of the N50-5’ss (N50 activation) in the small cell lung
cancer cell line H69. Wild type and mutant N exon/b-globin minigenes recapitulated N50 exon splicing in H69 cells, and
showed that the N-PU and the G2-G3 elements are required for N50 exon splicing. Biochemical and knockdown
experiments identified these elements as U2AF65 and hnRNP H targets, respectively, and that they are also required for N50
exon activation. Compared to normal MRC5 cells, and in keeping with N50 exon activation, U2AF65, hnRNP H and other
splicing factors were highly expressed in H69 cells. CLIP experiments revealed that hnRNP H RNA-binding occurs first and is
a prerequisite for U2AF65 RNA binding, and EMSA and CLIP experiments suggest that U2AF65-RNA recognition displaces
hnRNP H and helps to recruit other splicing factors (at least U1 70K) to the N50-5’ss. Our results evidenced novel hnRNP H
and U2AF65 functions: respectively, U2AF65-recruiting to a 5’ss in humans and the hnRNP H-displacing function from two
juxtaposed GGGG codes.
Citation: Ortun˜o-Pineda C, Galindo-Rosales JM, Caldero´n-Salinas JV, Villegas-Sepu´lveda N, Saucedo-Ca´rdenas O, et al. (2012) Binding of hnRNP H and U2AF65 to
Respective G-codes and a Poly-Uridine Tract Collaborate in the N50-5’ss Selection of the REST N Exon in H69 Cells. PLoS ONE 7(7): e40315. doi:10.1371/
journal.pone.0040315
Editor: Emanuele Buratti, International Centre for Genetic Engineering and Biotechnology, Italy
Received March 2, 2012; Accepted June 4, 2012; Published July 5, 2012
Copyright:  2012 Ortun˜o-Pineda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported with funds from CONACyT (Grants Nos.49355-M and 127557- M, and a Postgraduate Scholarship to COP). The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jvaldes@cinvestav.mx
Introduction
The alternative splicing mechanism generates vast numbers of
protein isoforms amplifying the eukaryotic proteome and affecting
human genetic diseases. Frequently, such diseases are caused by
mutations in splicing regulatory sequences [1] or by changes in the
relative concentrations of splicing factors affecting the spliceosomal
composition [2].
A clear example of splicing pattern-induced gene expression
changes is the neural phenotype observed in small cell lung cancer
(SCLC). This is partly due to the expression of the truncated (t)
REST (RE1-Silencing Transcription Factor) isoform (Fig. 1A, b)
[3,4], which modifies the expression of neuron-restricted genes
otherwise silenced by REST in non-neuronal cells. In several
SCLC cell lines, tREST is coded by the REST-N50 (a.k.a. sNRSF)
mRNA variant, which carries a premature stop codon due to the
neuronal (N) exon inclusion [4]. The N exon is localized between
exons V and VI, and its variable length of 4, 50 or 62 nucleotides
(nt) is determined by the selection of one of three alternative 5’ss
(here named N4-, N50- and N62-5’ss, respectively)(Fig. 1A)[5,6].
Whereas in neuroblastomas the N4-5’ss is mainly selected [6], in
the SCLC H69 cell line the N50-5’ss selection has been observed
only [4].
Early during spliceosomal assembly, the 3’ss is recognized by
the small subunit of the essential splicing factor U2AF, U2AF35.
The large subunit, U2AF65, interacts with U2AF35 and binds to
polypyrimidine tracts (Py) upstream of the 3’ss, by forming unique
hydrogen bonds with the Uracil edges and promoting the U2
snRNP binding to the branch point site [7,8]. A systematic analysis
of constitutive and alternative exons, revealed an enrichment of
polyuridine tracts (PU) within 100 nt following their 5’ss which
promote the inclusion of the adjacent exons [9] by TIA-1/TIAR-
mediated [10] or U2AF65-mediated [11] U1 snRNP 70K
recruitment to the 5’ss. Also, neural-specific exons are activated
by nSR100 (neural-specific Ser/Arg repeat-related protein of 100
kDa), which binds to proximal (1000 nt around the exon) intronic
C/U-rich motifs [12].
Recently, an array composed of G-rich [13], have been
implicated in the coordinated splicing regulation of neural-specific
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alternative exons. These events involve other splicing signals and
factors as well. For example, the glutamate receptor NMDA R1
neuronal exon cassette C1 is combinatorially regulated by an
exonic UAGG element and a GGGG code proximal to the 5’ss
[14], and the function of these elements is linked to the splicing
factor hnRNP H. The splicing of the c-src N1 exon is regulated by
the cooperative binding of hnRNP H and hnRNP F to an intronic
splicing enhancer, localized downstream of the 5’ss in front of the
exon [15]. The alternative splicing of several exons of the (PLP)/
DM20 gene require hnRNP H and hnRNP F recognition of a
complex GGGG-codes array [16], and the insulin exon 11 is
activated when hnRNP F binds intronic UAGGGA elements in
front of the upstream exon 10 and functionally interacts with
SRSF1 (SF2/ASF) bound to exon 11 [17].
A sequence analysis of the N exon environment (Fig. 1B)
revealed a PU, here referred as N-PU, localized 60 nt downstream
of the N50-5’ss, and three GGGG codes that may participate in its
activation: one comprising the N4 and juxtaposed to the N4-5’ss
(G1) and two downstream (G2-G3) the N exon.
Here we investigated N50 exon activation in H69 cells. N exon/
b-globin minigenes recapitulated N50 exon splicing when
transfected into H69 cells, and mutant minigenes showed that
the N-PU and the G2-G3 elements are required for N50 exon
splicing. Biochemical and knockdown experiments showed that
these elements are targets for U2AF65 and hnRNP H, respec-
tively, and that they are also required for N50 exon activation. In
agreement with the unique N50-5’ss selection in H69 cells and the
absence of N exon activation in the proxy to normal MRC5 cells,
U2AF65, hnRNP H and other splicing factors were highly
expressed in H69 cells. CLIP experiments revealed that hnRNP H
RNA-binding occurs first and is a prerequisite for U2AF65 RNA
binding and EMSA experiments showed that binding of U2AF65
to the N-PU displaces hnRNP H from the G2-G3 codes; these
hnRNP H and U2AF65 functions have not been previously
described. Finally, U2AF65 appears to promote U1 snRNP 70K
recruiting for N50-5’ss activation. Altogether, these findings are in
agreement with the model in which in MRC5 cells the N exon
could be repressed by hnRNP H binding to the GGGG codes,
whereas in H69 cancer cells, such repression might be relieved by
U2AF65 binding to the N-PU, whose recruiting appears to be
facilitated by hnRNP H, leading to N exon activation.
Results
The N-PU, G2-G3 codes, U2AF65, hnRNP H are essential
elements and factors for N50 activation and tREST
expression
In H69 cells, the splicing of the N50 exon in the REST pre-
mRNA originates the REST-N50 mRNA variant and its
corresponding truncated protein [4], however the mechanisms
and signals involved in such splicing mechanism are less
understood. To analyze the cues involved in the N50-5’ss
activation in H69 cells, a minigene construct containing N50
exon sequences (Fig. 1C) cloned between exons 1 and 2 of the b-
globin cDNA was made, transfected into H69 cells, and the in vivo
splicing products were analyzed by RT-PCR using primers
targeted to the b-globin exons (for primers and PCR conditions,
see Fig. S1). The N exon/b-globin minigene recapitulated the
splicing pattern of the N50 exon (Fig. 2, lane 2).
Figure 1. Splicing regulatory elements around the N exon. (A)
Schematic representation of the REST gene (drawing not to scale)
showing the transcription start site (right arrow), introns (thin lines),
lengths of relevant introns, constitutive exons coding for the UTR
(dashed boxes) and for the REST protein (white boxes), including the
alternative N exon (black box); the relative positions of the alternative
N4-, N50- and N62-5’ss appear underneath. Thick arrows indicate the
positions of the primers used to amplify the mRNA variants by RT-PCR.
The main possible mRNAs and proteins expressed in a) non-neuronal
cells and b) SCLC H69 cells are depicted also. Splicing of the N50 exon
introduces a stop codon. Nomenclature of protein domains: RD,
repressor domain; Zn-DBD, zinc-finger DNA-binding domain; PM,
Proline-rich motif; and Zn-RD, zinc-finger repressor domain. (B)
Genomic DNA from H69 and MRC5 cells was used to amplify 163 bp
(between virgules) that include the N exon by PCR and the sequence
identity between the cell lines was confirmed. The names of the
relevant transcript elements are shown under the sequence. The AG-UG
dinucleotides, corresponding to the 39ss, and the N4-, N50- and N62-
5’ss appear in italics; the upstream Py, G1-G3, and N-PU elements are
boxed in gray. (C) Unscaled drawings of the RNA molecules used in this
work. The top one is coded by the minigene constructs (271 nt
upstream, 62 nt of the N exon, and 72 nt downstream); the sequences
between virgules correspond to those shown in B. The full-length wild
type (flWT) and G2-G3,N-PU probes are also shown. Mutant versions
(without both elements or without N-PU) of the G2-G3,N-PU probe
were made also. The putative RNA binding sites for U2AF65 (triangles),
hnRNP H (black diamonds), TIA-1/TIAR (open circles), and nSR100 (white
diamonds) were predicted using the Splicing Rainbow software; the
symbols indicate their relative positions in the RNA molecules.
doi:10.1371/journal.pone.0040315.g001
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Around the N exon, multiple putative targets of splicing factors
were identified (Fig. 1C). A N-PU (downstream of the N62-5’ss),
probably recognized by the splicing activator U2AF65 which has
been reported to promote U1 snRNP recruitment to weak 5’ss
[11]. Also, several PU sites were found; these are cognate targets of
the activator of the neurofibromatosis type 1 exon 23a TIA-1/
TIAR [18]. Three GGGG codes (the N4 conforming code G1,
juxtaposed to the N4-5’ss, and codes G2 and G3 localized 6
nucleotides upstream the N-PU) were found. These elements may
be recognized by the splicing modulator of neuronal exons hnRNP
H [14]. Finally, four C/U elements were identified, which could
be probably recognized by the activator of the REST N4 exon,
nSR100 [19].
This complex array of elements suggest their possible involve-
ment in the preferred N50- over N4- and N62-5’ss selection in
H69 cells. To test this, N-PU mutant (UUUUUU to GAUAUC),
G2-G3 mutant (GGGGGUGGGGG to CACGGUCACGG) and
G2-G3,N-PU double mutant minigenes were analyzed as before.
We found that the single mutants rendered 20–30% less N50 exon
inclusion, coordinated with a proportional increase in N exon-
skipped and partially spliced products (Fig. 2, lanes 3 and 4). In the
double mutant N50 splicing was further reduced (Fig. 2, lane 5).
These results suggest that both N-PU and G2-G3 elements are
required for N50 exon activation.
Given that there are no N exon sequence differences between
H69 and MRC5 cell lines (not shown), N50 activation in H69 cells
probably obeys to cellular context. Therefore, we investigated
whether the nuclear factors U2AF65 and hnRNP H from H69
cells could differentially recognize the N exon RNA. Nuclear
extracts (NEx) from H69 and MRC5 cells were UV cross-linked to
synthetic flWT transcripts (Fig. 1C). Albeit enhanced signals of
p100 and p90 were observed in H69 nuclear proteins, the signals
of p65 and p49 were particularly strong (Fig. 3A, lanes 1 and 2),
which might correspond to U2AF65 and hnRNP H, respectively.
To confirm the identity of these proteins and to further delineate
the elements recognized by these factors, NEx of both cell lines
and a shorter version of the probe (G2-G3,N-PU) were used in
CLIP assays. As before, a 65-kDa nuclear protein from H69 cells
was UV crosslinked to the probe (Fig. 3B, compare lanes 1 and 2),
and U2AF65 was precipitated from H69 (lane 4) but not from
MRC5 NEx (lane 5). Unrelated antibodies rendered no CLIP
signals with either cell line (lanes 5 and 6). In agreement with this,
complex formation between rU2AF65 and N-PU mutant probes is
reduced by 80% in EMSA (Fig. S2), suggesting that the N-PU is
necessary for U2AF65 recruiting to the N exon alternative 5’ss.
Likewise, hnRNP H was precipitated only from H69 cells after
UV crosslinking to the G2-G3,N-PU probe, whereas no signal
was observed when an unrelated antibody was used (Fig. 3B,
lanes 10 and 11, respectively). HnRNP H was detected in
immunoprecipitation-only and UV crosslinking-only control
reactions (Fig. 3B, lanes 7 and 9, respectively); the UV crosslinking
reactions showed a 48-kDa protein, probably corresponding to
TIA-1/TIAR, and no signal was observed with an unrelated
antibody immunoprecipitation (lane 8). Collectively, these results
suggest that U2AF65 and hnRNP H bind the N-PU and the G2-
G3 codes, respectively.
In agreement with their reported functions, we expected that
N50 activation and tREST expression could depend on the
U2AF65 and hnRNP H splicing promoting activities. To test this
possibility we monitored N50 inclusion and the expression of
REST isoforms after U2AF65 (Fig. 4A) and hnRNP H (Fig. 4D)
knockdown in H69 cells. Compared to the negative control siRNA
(Fig. 4A, lane 1), U2AF65 knockdown resulted in N50 skipping,
and in reduced tREST expression (lane 2); siRNA treatments did
not affect the expression of other splicing (not shown) and
housekeeping proteins. Reciprocally, the exogenous U2AF65
expression in MRC5 cells resulted in N50 inclusion, increased
tREST expression, and as expected, REST downregulation
(Fig. 4B, lane 1). Figure 4C shows the REST mRNA variants
and protein isoforms in untreated H69 and MRC5 cells. To test
the requirement of hnRNP H, in vivo splicing assays were carried
out with the wild type and mutant N exon/b-globin minigenes in
hnRNP H-knockdown H69 cells, monitoring the N50/b-globin
exon 2 splicing products by RT-PCR. Notably, hnRNP H
knockdown resulted in the accumulation of unspliced RNA
precursor (Fig. 4D, compare lanes 4 and 5), and the N-PU, G2-
G3 and double mutants increased the accumulation of the
unspliced precursors even further. Moreover, mutations of the
G2-G3 result in only unspliced product, and the splicing of N50
does not occur all. Collectively, these results suggest that U2AF65
and hnRNP H, the N-PU and G2-G3 elements and their
respective interactions are essential for N50 exon activation. They
also suggest that additional G2-G3-binding factors could be
important for N50-5’ss recognition, and that hnRNP H might be a
prerequisite for splicing factors recruiting to the N50-5’ss vicinity.
Figure 2. N-PU and G2-G3 codes are required for N50 exon
activation in H69 cells. Mutant N-PU and G2-G3 elements negatively
affect N50 exon inclusion. Cells were transfected with the wild type
(lanes 1 and 2) or mutant N50/b-globin minigenes (lanes 3–5). 24 h
post transfection, N exon inclusion between b-globin exons 1 and 2 was
monitored by RT-PCR (with primers T7 and SP6). No RT (- RT) PCR
control reaction appears in lane 1. The plot below shows the
quantification of the spliced and partially spliced mRNAs in the
indicated lanes. The absence of either element decreased N50 exon
activation, albeit the lack of the G2-G3 rendered more exon skipping
and partially spliced products.
doi:10.1371/journal.pone.0040315.g002
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Confirming our previous findings, and in coordination with the
REST-N50 mRNA expression, U2AF65 and hnRNP H expres-
sion was more robust in H69 cells (Fig. 5A). As expected, TIA-1/
TIAR and nSR100 were highly expressed in H69 cells also
(Fig. 5B).
Mechanistic interplay of U2AF65/N-PU and hnRNP H/G2-
G3 in the recognition of the N50-5’ss
Several biochemical approaches were used to test the interplay
of the nuclear factors U2AF65 and hnRNP H with the N-PU and
G2-G3 codes in the recognition of the N50-5’ss. Our previous
experiments prompted the idea that RNA-bound hnRNP H might
be a prerequisite for the recruitment of other nuclear factors to the
N50-5’ss (Figs. 3B and 4D). To gain insights on this possibility,
CLIP assays were carried out with the G2-G3,N-PU probe and
whole or hnRNP H-depleted NEx (Fig. S3) from H69 cells, that
were immunoprecipitated with U2AF65 antibodies. The recov-
ered wild type RNA was amplified by RT-PCR and quantified.
The absence of hnRNP H affected U2AF65-bound RNA recovery
by 60% (Fig. 6A, lane 3), whereas no significant binding reduction
was observed when the extracts were depleted with an unrelated
antibody (lane 4). These, and previous results (Figs. 2 and 4)
support the notion that hnRNP H bound to the G2-G3 elements
might be a prerequisite for the recognition of the NP-U by
U2AF65.
Therefore, similar experiments were carried out to explore the
kinetics of hnRNP H and U2AF65 binding to the N exon wild
type RNA. Given that additional G-rich and uridine-rich elements
are present in the RNA and that the CLIP assays were carried out
with whole NEx, to discriminate stable and direct (i.e. not
mediated by other nuclear factors) protein/RNA interactions, the
signals of mutant RNAs lacking the G2-G3 and N-PU elements
were subtracted from those of the wild type RNA. The RNA
immunoprecipitated with hnRNP H peaked between 4–8 min,
and plummeted at 10 min (Fig. 6B). However, as expected from
the different protein isoforms and differential RNA structure
recognition [20], small amounts of RNA were immunoprecipitat-
ed with U2AF65 throughout, reaching a maximum at 10 min
(Fig. 6B). These data might reflect that hnRNP H recognizes the
G2-G3 elements early during complex assembly, and that either
by protein isoform substitution or RNA structure stabilization,
U2AF65 binding to the N-PU is delayed. Furthermore, these data
also suggest that U2AF65 RNA-binding displaces hnRNP H
binding to the juxtaposed G2-G3 elements.
Since TIA-1 and TIA1-like proteins are able to bind to U-rich
motifs downstream of 5’ss facilitating its recognition [9] and that
these proteins are abundantly expressed in H69 cells, CLIP assays
were carried out to investigate whether these proteins were able to
bind to the N-PU. Similar amounts of wild type- and mutant-N-
PU RNAs were recovered with the TIA-1/TIAR antibodies
(Fig. 6C), suggesting that these proteins bind to one or more
upstream U-rich motifs, different to the N-PU. No RNA was
recovered with a 3’ss control probe.
In view of the above results, and that binding of U2AF65 to
pyrimidine-rich sequences in front of a 5’ss can activate the ss by
means of U1 snRNP recruiting [11], it is possible that to exert its
5’ss activating function, U2AF65 might displace hnRNP H from
G2-G3 by a steric competitor effect. To investigate this, the
complexes formed with the wild type probe and MRC5 NEx
(Fig. 7, lanes 2 and 6), were super-shifted with anti-hnRNP H
antibodies (lanes 3 and 7), but not with antibodies against
unrelated antigens (lane 4). However, super-shifting of the
complexes was challenged with increasing amounts of rU2AF65
in a dose dependent manner (Fig. 7, lanes 8–10, respectively),
suggesting that U2AF65 sterically hinders hnRNP H binding to
the intronic G2-G3 elements.
The activating role of U2AF65 was explored further. Mimicking
H69 and MRC5 cellular contexts, U2AF65-depleted H69 NEx
was not as efficient as whole NEx to recruit EMSA complexes with
the G2-G3,N-PU probe, and the complexes formed with the
same probe and MRC5 NEx were supershifted with rU2AF65
(Fig. S4). This suggested that U2AF65 could participate in
recruiting other splicing factors to the N50-5’ss. Recombinant
U2AF65 was able to form complexes with the G2-G3,N-PU
probe in a dose dependent manner (Fig. 8A, lanes 1–4), and larger
complexes were formed with MRC5 NEx in the presence of U1
70K antibodies (lane 5). The signal of the supershifted complexes
increased with the amount of rU2AF65 (lanes 6–7), suggesting that
U2AF65 might facilitate U1 snRNP recruitment to the N50-5’ss as
previously described [11]. In addition, efficient complex formation
was observed with the probe and NEx from H69 cells, but not with
extracts in which the 5’ end of U1 snRNA was degraded by RNase
H-mediated digestion with a complementary oligonucleotide
(Fig. 8B, lanes 1–3, respectively); the use of a scrambled
oligonucleotide as a control for U1 snRNA degradation did not
affect complex formation (lane 4). Furthermore, pull-down assays
were carried out with NEx from H69 cells and Sepharose beads
covered with rSRSF3, rU2AF65, the rU2AF65-RS domain or
BSA, and the precipitated proteins were detected by western blot.
U2AF65 and the rU2AF65-RS domain (Fig. 8C, lanes 2 and 3,
respectively) were able to pull-down U1 snRNP 70K and TIA-1/
TIAR. No U1 snRNP 70K was pulled-down with the RS domain
of rSRSF3 or BSA-covered beads (Fig. 8C, lanes 1 and 4,
respectively). Conversely, rU2AF65 did not recruit hnRNP H
(bottom panel). Altogether, the results suggest that U2AF65
Figure 3. U2AF65 and hnRNP H bind to probes containing the
N-PU and the G2-G3 codes. (A) flWT N exon synthetic transcripts
containing the three GGGG codes and the N-PU, and NEx from H69
(lane 1) and MRC5 (lane 2) cells were used in UV crosslinking
experiments. Enriched p64 and p50 proteins in H69 are indicated with
arrowheads. (B) UV crosslinking (lanes 1 and 2) and CLIP (lanes 3–6)
assays were carried out with G2-G3,N-PU synthetic RNAs, NEx from
MRC5 (lanes 1, 3 and 5) or H69 cells (lanes 2, 4 and 6), and with
antibodies against U2AF65 (lanes 3, and 4) or an unrelated antigen
(lanes 5 and 6). Immunoprecipitation (lanes 7 and 8), UV crosslinking
(lane 9) and CLIP (lanes 10 and 11) assays were carried out with the
same synthetic RNAs and NEx from H69 cells, using antibodies against
hnRNP H (lanes 7 and 10, respectively) or an unrelated antigen (lanes 8
and 11, respectively). A low molecular mass unidentified protein cross-
reacted with the probe (asterisk).
doi:10.1371/journal.pone.0040315.g003
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Figure 4. U2AF65 and hnRNP H are required for N50 exon activation in H69 cells. (A) U2AF65 knockdown downregulates REST-N50
mRNA and tREST expression in H69 cells. H69 cells were treated with universal control (iUC) or U2AF65 siRNAs (lanes 1 and 2, respectively), (B)
Overexpression of U2AF65 in MRC5 cells promoted REST-N50 mRNA and tREST expression. MRC5 cells were transfected with the
U2AF65 cDNA (lanes 1) or with empty pcDNA3 vector (lanes 2). 24 h or 36 h post-transfection of siRNAs or cDNAs, respectively, the mRNAs coding for
U2AF65, N50-REST, and Actin were monitored by RT-PCR. Protein expression of U2AF65, REST, tREST, and Actin was monitored by western blots as
well. (C) Steady state expression profiles of REST mRNA variants (lanes 1–3) and protein isoforms (lanes 4–5) in H69 (lanes 1 and 4) and MRC5 (lanes 2
and 5) cells, respectively. No RT (- RT) PCR control reaction appears in lane 3. (D) hnRNP H knockdown leads to accumulation of unspliced
N50/b-globin precursor. H69 cells were treated with iUC (lanes 1, 3 and 4) or hnRNP H siRNAs (lanes 2, 5–8). After 24 h, the cells were transfected
with the wild type (lanes 3–5) or mutant N50/b-globin minigenes (lanes 6–8). 24 h post- transfection, N50/b-globin exon 2 splicing was monitored by
RT-PCR (with primers SP6 and rtN62). No RT (- RT) PCR control reaction appears in lane 3. hnRNP H knockdown increased the unspliced precursors
two-fold. Accumulation of the precursor increased up to 3 times when one or both of the N-PU (black flags) or G2-G3 (white flags) were mutated.
Notably, G2-G3 mutants rendered no spliced products, and the N62/2 (*) product was obtained in double transfection experiments only. The PCR
products and proteins were quantified densitometrically using the ImageJ software. IntDen % represents the expression change of the indicated
protein or mRNA compared to their respective control treatment.
doi:10.1371/journal.pone.0040315.g004
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Figure 5. tREST expression correlates with the robust expression of U2AF65, hnRNP H, and other splicing factors in H69 cells. (A)
The expression of nuclear U2AF65, hnRNP H and snRNP U1 70K in H69 (black bars) and MRC5 (white bars) cells was monitored by western blots.
Proteins were quantified densitometrically using the ImageJ software. IntDen % represents the expression change of the indicated protein in H69
cells compared to MRC5 cells. (B) Whole cell protein extracts from MRC5 and H69 cell were probed with antibodies against nSR100, TIA-1/TIAR and
Actin antibodies. A robust expression of nSR100 and TIAR was detected in H69 cells only.
doi:10.1371/journal.pone.0040315.g005
Figure 6. U2AF65/N-PU and hnRNP H/G2-G3 interplay in the N50 exon recognition. (A) hnRNP H-RNA recognition is a prerequisite
for U2AF65-RNA binding. The wild type RNA was incubated with whole (lane 2), hnRNP H-depleted (lane 3), and unrelated antigen-depleted H69
NEx (lane 4) or beads alone (lane 5). Then CLIP assays were carried out using U2AF65 antibodies and the recovered bound RNA was monitored by RT-
PCR and quantified densitometrically. No RT (– RT) control PCR appears in lane 1. In the absence of hnRNP H, 60% less RNA was recovered with the
U2AF65 antibodies, and no difference was observed in the absence of an unrelated antigen. (B) Kinetics of U2AF65- and hnRNP H-RNA
binding. H69 NEx were incubated with wild type or mutant (G2-G3,N-PU-less) RNA probes during the indicated times at room temperature. Then,
CLIP assays were carried out with U2AF65 or hnRNP H antibodies and the recovered RNAs were amplified by RT-PCR (top panel, electrophoresis of the
amplified products) and quantified densitometrically (plot at the bottom). At each time point, IntDen values obtained from the CLIP with the mutant
RNA were subtracted from those obtained with wild type RNA in order to discriminate indirect protein-RNA interactions (e.g. mediated by additional
factors) and unspecific binding to G-like and PU-like motifs. Significant amounts of hnRNP H-bound RNA are recovered as early as 4 min plummeting
at 10 min, coinciding with the onset of U2AF65-bound RNA recovery. (C) TIA-1/TIAR is able to bind to multiple poly-U tracts. Different probes
(wild type G2-G3,N-PU, G2-G3,mutant N-PU, and 3’ss control) were used in CLIP experiments as in B. Immunoprecipitations were carried out with
antibodies against TIA-1/TIAR and U2AF65, and the recovered RNAs were amplified by RT-PCR and quantified. IntDen % represents the expression
change of the indicated protein or mRNA compared to their respective control treatment. ND, not detected.
doi:10.1371/journal.pone.0040315.g006
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binding to the N-PU hinders hnRNP H G2-G3 recognition and
promotes, together with TIA-1/TIAR, U1 snRNP 70K recruit-
ment to the 5’ss.
Discussion
The role of the REST protein in the phenotype of H69
cells
REST expression profiles in H69 cells directly affect the
determination of the transformed phenotype. In fact, transfection
of the N50-REST cDNA into MRC5 cells modifies the expression
profiles of the REST target genes RRAD (Ras-related associated
with diabetes) and TMS-1 (target of methylation induced
silencing-1) (Fig. S5). In this respect, it has been suggested that
truncated REST isoforms function by antagonizing cREST;
however their roles seem to be much more diverse. The fact that
REST4 has not direct effect on the activation or repression of
synapsin I in mouse NS20Y cells [21], suggests a different role for
this splicing variant instead of antagonizing REST function, or
directly activating REST target genes [22,23]. Alternatively, an
increasing number of REST-related small RNAs and the many
profiles of REST interactions could explain new roles for REST
neuronal isoforms [24,25]. Whereas constitutively expressed
REST suppresses a vast number of the neuronal genes in non-
neuronal tissues [26,27], a decrease of REST is essential for
establishing and maintenance of neuronal fates. In fact, REST is
post-translationally downregulated in early stages of neurogenesis
allowing the expression of neuronal genes [28]. Concomitant with
the REST degradation, the persistence of REST transcripts after
protein degradation in neurogenesis and adult neuronal tissues
correlates with truncated REST (mRNA) variants, suggesting that
the solely REST degradation is not sufficient for the acquisition of
neuron fates [6,28]. Recently, however, Raj et al. [19] showed
that neurogenesis is controlled by a cross-regulation between
nSR100 and REST.
As previously demonstrated by Coulson and coworkers [4], here
we observed mRNA and REST protein as well as the splicing
variant REST-N50 in H69 cells, cell that express neuronal traits
(Fig. 4). However, works from Neumann and coworkers failed to
detect either the mRNA or REST protein suggesting a transcrip-
tional downregulation of REST and the consequent shortage of
REST protein [29]. Our experiments demonstrated the presence
of REST and tREST and evidenced rapid degradation of REST
after translation inhibition with emetine as reported to occur
during neurogenesis process [28]. Moreover, we found REST
stabilization in MG132 treated H69 cells suggesting that REST is
degraded via proteasome (Fig. S6). Interestingly, tREST expres-
sion remained in translation inhibition experiments even after long
time; although other possibilities may explain tREST endurance, it
is possible that this isoform does not undergo proteasome
degradation due to its lack of many potential ubiquitination sites.
Also, in agreement with previous findings [19], REST downreg-
ulation may also obey to the robust expression of nSR100 in H69
cells.
N50 splicing mechanism in H69 cells
Previous works have identified multiple 5’ss surrounding the
REST N exon, suggesting tissue-specific activation profiles [5,6].
Our findings are in agreement with the N50 exon sequence
features which reflect the preferred selection of the N50-5’ss over
the remaining alternative ss. The N50-5ss is strong and is
surrounded by U- and G-rich tracts (e.g. the N-PU and G2-G3
codes), located downstream the N50-5’ss, which resemble those
found in many neuronal exons [9,10,14]. We have shown that
N50 exon inclusion depends on the combinatorial function of a
complex array of splicing regulatory signals and robust expression
of U2AF65, hnRNP H and other splicing factors (Figs. 2, 4, and 5).
Interestingly, mutations of the G2-G3 codes had a stronger
negative effect on N50 exon inclusion than N-PU mutants (Figs. 2
and 4D), suggesting that hnRNP H binding to the G2-G3 has a
more relevant role in N50 exon activation. These findings also
suggested that hnRNP H and other factors binding to and nearby
the G2-G3 occurred first, and that could facilitate U2AF65
recruitment to the N-PU. Although other factors are found in the
RNA complexes, the biochemical data showed direct U2AF65/N-
PU and hnRNP H/G2-G3 RNA-protein binding (Figs. 3, and 6).
We also observed more pronounced hnRNP H supershift signals
in G1-containing RNAs (Fig. S7). Since the G1 is juxtaposed to
the N4-59ss, it is probable that hnRNP H and additional factors
recruited in the G1 element block the N4-5’ss.
The binding and in vivo splicing assays (Figs. 2, 4D, and 6A)
indicated that hnRNP H and the G2-G3 codes are essential and a
prerequisite for U2AF65 recruitment to the N-PU and N50 exon
inclusion. In agreement with this, the time course experiments
(Fig. 6B) strongly indicated that hnRNP H initially forms stable
RNA-protein complexes, followed by U2AF65 recruitment to the
N-PU and hnRNP H dissociation. It has been argued that
U2AF65 initially binds to the RNA and that such complex
undergoes additional conformational rearrangements to maximize
binding interaction, thus entailing multiple adjustment stages [20].
Figure 7. U2AF65/N-PU recognition displaces hnRNP H binding
to the G2-G3 motifs in a dose dependent manner. Supershift
experiments were carried out with the G2-G3,N-PU probe (free probes
are in lanes 1 and 5), NEx from MRC5 cells (lanes 2–4, and 6–10), anti-
hnRNP H antibodies (lanes 3, 7–10), antibodies against an unrelated
antigen (lane 4), and increasing amounts of rU2AF65 (2, 4, and 6 mg;
lanes 8–10, respectively). The complexes supershifted by the hnRNP H
antibody (a-H cx) migrated back to the original position of the NEx
complexes (NEx cx) as the amount of rU2AF65 increased. Probe and
factors depicted as in Fig. 1C.
doi:10.1371/journal.pone.0040315.g007
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Therefore U2AF65-RNA associations at short times (4 – 8 min)
may be transient and attributed to both protein and RNA
conformational dynamics, or to a possible interplay between many
other factors. It is possible that the hnRNP H dissociation after
U2AF65 binding may be caused by steric hindrance or by the
RNA refolding, due to juxtaposition of the G2-G3 and the N-PU
elements.
U1 snRNP is the first sub complex thought to bind the 5’ss
during the spliceosome assembly. It is accepted that many
auxiliary-splicing factors can promote weak 5’ss recognition by
binding to enhancer sequences [30,31]. Despite of U2AF65
interactome is thought to be large, little has been reported
concerning U2AF65-U1 snRNP interactions [11,32]. Forch and
colleagues showed that the in vitro U2AF65 binding to a PU tract
near to the 5’ss of the mls-2 RNA from Drosophila can promote U1
snRNP recruitment [11]. In agreement with this, we found that
the presence of the U1 snRNP in the supershifted complexes was
proportional to the amount of rU2AF65 suggesting U2AF65
requirement (Fig. 8) and that depletion of U2AF65 diminishes
complex formation (Fig. S4). In addition, in U1 snRNA-depleted
Figure 8. The RS domain of U2AF65 promotes U1 snRNP recruitment to the N50-5’ss. (A) The G2-G3,N-PU probe (free probe in lane 1)
was used in EMSA experiments with increasing amounts of rU2AF65 (1–3 mg) forming the complexes r65 cx (lanes 2–4, respectively). The same probe
was incubated with MRC5 NEx forming the complexes NEx cx (lanes 5–7). NEx cx were supershifted with anti-U1 70K antibodies (a-U1 70k cx) in the
presence of 1–3 mg of rU2AF65 (lanes 5–7, respectively). The amount of a-U1 70k cx increased with the amount of rU2AF65. (B) The same probe (free
probe, lane 1) was used in EMSA experiments with NEx from H69 cells (lane 2), or with extracts incubated with oligonucleotides targeted to the 5’ end
of the U1 snRNA and treated with RNase H (U1 k.o.; lane 3), or with RNase H-treated extracts incubated with scrambled oligonucleotides (c.o.; lane 4).
Probe and factors depicted as in Fig. 1C. (C) Nickel or protein-A Sepharose (S) beads covered with rSRSF3-(S), rU2AF65, and the SR domain of U2AF65
(rU2AF65-RS) were used in pull-down experiments. U1 70K, TIA-1/TIAR, and hnRNP H (top, middle, and bottom panels, respectively) were monitored
by western blots. Both snRNP U1 70K and TIA-1/TIAR were able to interact with U2AF65 and its RS domain (lanes 2, and 3) but not with a different
splicing protein, rSRSF3 (lane 1). BSA covered beads were used for blank controls (lane 4); in these lanes protein-A copurified with BSA. No hnRNP H
was pulled-down with rU2AF65. The cartoon depicts the possible U1 snRNP and TIA-1/TIAR interactions with U2AF65 in the recognition of a 5’ss.
doi:10.1371/journal.pone.0040315.g008
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H69 NEx no evident complex formation was observed indicating
the requirement of the U1 snRNA for N50-5’ss and U1 snRNP
association (Fig. 8B). U2AF65 depletion in these experiments
mimicked U1 snRNA degradation, reinforcing U1 snRNP
recruitment via U2AF65 (Fig. S8). Furthermore, pull down assays
showed that the RS domain of U2AF65 is enough to recruit the
U1 snRNP. Given the robust expression of TIA-1/TIAR in H69
cells, and that TIA-1/TIAR binds poly-U tracts nearby the G2-
G3 elements, and because it precipitates in U2AF65 pull-down
experiments, it is possible that both TIA-1/TIAR and U2AF65
actively participate in U1 snRNP recruitment to the N50-5’ss.
Collectively, our results suggest that the initial hnRNP H
binding to the G2-G3 codes is a prerequisite for U2AF65
recruiting to the N-PU tract. Then U2AF65 along with other
factors might help U1 snRNP recruitment to the N50-5’ss for N
exon activation.
We found here that N exon is a very versatile sequence with a
complex array of splicing signals, and its activation in H69 cells
depends on the relative amounts of hnRNP H and U2AF65.
Although further studies are needed to unveil the activation of the
N4- and N62-5’ss, we gained some insights in a novel-activating
role of hnRNP H, being a prerequisite for U2AF65 recruiting to
nearby sequences.
The U2AF65 hnRNP H-displacing function evidenced here is
new, and might have been acquired early in evolution. This
particular function resembles that of SRSF1 and SRSF2 that bind
to juxtaposed GGGG codes downstream of the chicken tropomy-
osin exon 6B displacing hnRNP A1 from these sites and promoting
exon inclusion [33]. Also, such function resembles that of hnRNP
A1 when displacing U2AF65 from non-AG-containing/uridine-
rich 3’ss [34]. This is the first report on the recruitment of U2AF65
downstream of the N50-5’ss for its activation in a human pre-
mRNA.
Finally, we show here precedents for the repressing and
recruiting functions of hnRNP H (in a consecutive fashion) and
U2AF65 (in a simultaneous manner) along the splicing mecha-
nisms associated with cancer cells.
Materials and Methods
Cell cultures and nuclear extracts
The human H69 (SCLC), A549 (lung adenocarcinoma epithe-
lial; used in supplementary experiments), and MRC-5 (normal
diploid secondary lung fibroblasts) cells were from ATCC
(Manassas, VA, USA). Cells were cultured with RPMI and
DMEM media, respectively, both supplemented with 10% fetal
bovine serum. Nuclear extracts were made according to the
Dignam protocol [35].
PCR and Computational tools
H69 cells genomic DNA containing 593 nt around the N exon
was amplified by PCR, using primers Seq1s and Seq1as (primer
sequences and PCR conditions are listed in Fig. S1). The
amplified DNA was sequenced and 163 nt of the N exon and
intron sequences were analyzed for ss strength using the on-line
Alternative Splice Site Predictor (University of Sevilla). The tool
uses pre-processing models for position-specific score matrixes and
a backpropagation network for the positive hits. Therefore, low
scores represent false ss, and values above the cutoff result in
reduced detection of alternative isoforms and cryptic ss. The
Splicing Rainbow was used to search for putative binding sites for
splicing factors.
siRNAs, constructs, transfections, western blotting and
densitometries
The pre-characterized U2AF65 (HSS117616), hnRNP H
(HSS104905), and negative universal control (46-2001) siRNAs
were purchased from Invitrogen. To construct the wt and mutant
REST b-globin-N exon minigenes we first amplified the first two
exons and intron of the b-globin gene with primers gloF and gloR.
The fragment was cloned in the pCR2.1 plasmid. Next, the N
exon sequencing fragment was used as template to amplify the wt,
PU mut, G2-G3 mut and double mutant N exons using the
forward primer 2REN/IVs and the reverse primers PU-rev, PU
mut, G2G3m-as, and d-mut, respectively. Each fragment was
inserted into the Bbs I site of the b-globin intron of the pCR2.1
clone, and each intermediary was subcloned into the pcDNA3
plasmid digested with Kpn I and Xho I. Clones were verified with
Nsi I digests and sequencing. Plasmids were purified with Plasmid
Midi Kit (QIAGEN), and transfected into human cells. The
primers U2AF65F and U2AF65R were used to amplify de cDNA
of U2AF65 by RT-PCR. The fragment was cloned into the Bam
HI and Xho I sites of the pPROEX HTb plasmid. To maintain
the RS domain of U2AF65, the Hind III-Sma I fragment was
deleted by religation. Likewise, to maintain the SR domain of
SRSF3, the Sma I-Xho I fragment was deleted from a cDNA
SRSF3 clone in pGEX-2T. For overexpression experiments, the
cDNA of U2AF65 was cloned in the plasmid pcDNA3.1. For
transfection experiments, plasmids (2 mg) or siRNAs (20 nM) were
transfected with Lipofectamine 2000 in six-well culture plates
following the manufacturer’s instructions (Invitrogen), and mRNA
and protein expression were analyzed. Total RNA was prepared
with RNasy Kit following the manufacturer’s instructions (Qia-
gen). For reverse transcription, Superscript II (Invitrogen) was
used. For H69 and MRC-5 whole-cell extracts, cells were
disrupted in lysis buffer (10 mM NaCl2, 10 mM Tris.HCl, pH
7.5, 1.5 mM MgCl2 and 1% NP-40), and 10 mg were resolved in
10% polyacrylamide gel. Antibodies against REST, hnRNP H,
hnRNP F, pan-SRSF, U2AF65, U1 70K (Santa Cruz Biotech-
nology, Inc.), and Actin (a gift from J.M. Herna´ndez) were used for
western blotting, CLIP, supershift, and pull-down assays. Digital
image densitometries of PCR products and protein bands were
carried out, from at least three experiments each, with the ImageJ
software and expressed as Integrated Density (IntDen) or its
percent.
RNA labeling
DNA templates were amplified by PCR. For UV crosslinking
and supershift assays, RNAs carrying the exon N were transcribed
in vitro using the RiboprobeH System-T7 (PROMEGA) as
instructed by the manufacturer, RNAs were purified from a 5%
denaturing acrylamyde gel using the RNA elution buffer (0.3 M
sodium acetate, 0.2% SDS). RNA was extracted with phenol:-
chloroform:isoamyl alcohol and ethanol precipitated.
UV crosslinking and crosslinking-immunoprecipitation
(CLIP)
One mg of NEx was incubated with 200 fmole of 32P-labeled
RNA for 30 min at 4uC in splicing buffer (5mM HEPES pH 7.9,
0.6% polyvinyl alcohol, 20 mM creatine phosphate, 10% glycerol
and 0.4 mM ATP). After incubation RNA-bound NEx were UV
irradiated for 20 min at a wavelength of 254 nm on ice, then
incubated with 0.5 mg of RNAse A for 30 min at 37uC, and
immunoprecipitated as described [36], or treated for electropho-
resis. In some cases 10 nM Psoralen was added in the UV
crosslinking reaction. For RNA binding assessments, CLIPs were
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carried out with cold RNA and precipitates were washed 3 times
with washing buffer. Pellets were treated with Proteinase K-SDS
and the bound RNA probe was extracted with phenol-chloroform
and PCR-amplified with primers N4T7-fwd and PU-rev.
EMSA and protein purification from RNA-protein
complexes
Splicing reactions were assembled in 10 ml of binding buffer
(50 mM Hepes-KOH, pH 7.6, 40 mM MgCl2, 20 mM spermi-
dine, 0.1 mM DTT, 0.5 mM EDTA, 1.5 mM ATP and 20%
Glycerol) containing 10 mg of nuclear extract and 0.4 mg/mL of
tRNA, and were incubated for 15 minutes at room temperature
(r/t). 2000 cpm of 32P-labelled substrate RNA was added and
incubated for 15 minutes at r/t. Samples were loaded on a 4.0%
native polyacrylamide gel, electrophoresed, and visualized by
autoradiography. Proteins were purified from sliced RNA-protein
complexes as previously described [37].
rU2AF65 expression and purification
Plasmids pProEXHTb-U2AF65 (or the RS domain of U2AF65)
were transformed into E. coli BL21, incubated at 37uC (OD=0.6–
0.8) and induced with IPTG 0.2 mM during 4 hours. Proteins
were isolated from bacterial pellets in denaturing conditions, as
indicated by the manufacturer (the QIAexpressionistTM), and
renatured by sequential dialysis in buffers with decreasing amounts
of urea, and later incubated on ice overnight. Glycerol (20%) and
protease inhibitors were added. Proteins were stored at 270uC
until use.
Pull-down assay
Ten mg of 6xHis-tagged protein (U2AF65-RS domain or full-
length) were bound to Ni-NTA beads in binding buffer (10 mM
Tris, 100 mM N9H2PO4.H2O, pH=8.0) for 1 h at r/t. Beads
were collected by centrifugation, washed three times with PBS and
incubated 30 min in 300 ml of 10% Bovine Serum Albumin (BSA)
at 4uC. The beads were then incubated overnight at 4uC with
200 mg of H69 NEx in 400 ml of PBS and unbound proteins were
washed three times with PBS by centrifugation. Bound proteins
were identified by western blot.
Supporting Information
Figure S1 Oligonucleotides used in this work. Primers
used to amplify the REST, RRAD, TMS-1 and Actin cDNAs.
The GA3PDH cDNA was amplified with primers reported by
Choi-Lundberg and Bohn. 1995. Brain Res. Dev. Brain Res. 85
(1): 80-8. The primers used to amplify the DNA templates for run-
off transcription; sequencing and plasmid constructions are also
shown. The PCR amplification conditions were preceded and
followed by a denaturing cycle at 94uC for 5 min, an extension
cycle at 72uC for 7 min, respectively.
(PDF)
Figure S2 The N-PU is a bona fide poly-Uridine tract
recognized by U2AF65 from H69 cells. The wild type N-PU
(lanes 1–4) or mutant N-Pn (lanes 5–8) RNAs (shown at the top)
were used in EMSA experiments with 2 mg (lanes 2 and 6), 4 mg
(lanes 3 and 7) or 6 mg (lanes 4 and 8) of rU2AF65; free probes
were run in lanes 1 and 5, respectively. The two remaining
uridines in the mutant RNA (UUUUUU to GAUAUC) account
for the residual (roughly 20%) rU2AF65 complexes (r65 cx),
suggesting that the N-PU is necessary for U2AF65 recruiting to the
N exon alternative 5’ss. An empty arrowhead indicates a
structured form of the mutant probe.
(PDF)
Figure S3 hnRNP H immunodepletion. NEx from H69
cells were depleted using antibodies against an unrelated antigen
(Dur) or against hnRNP H (DH). hnRNP H antibodies were used
to probe western blots after immunodepletion. The hnRNP H (P
H) and unrelated proteins (P ur) bound to the pellets after
immunodepletions were analyzed also. To control the hnRNP H
depletion, the same membrane was stripped and incubated with
antibodies against U2AF65 (lower panel). An asterisk indicates
residual hnRNP H after stripping.
(PDF)
Figure S4 U2AF65 is necessary for complex recruiting at
the N50-5’ss. The wild type probe (shown at the top; lanes 1 and
5) was used in EMSA with NEx from H69 cells (lane 2), or with
H69 NEx depleted of U2AF65 (DU2AF65; lane 3) or depleted of
an unrelated antigen (Dunrel; lane 4). Complex formation was
reduced with the DU2AF65 NEx. Reciprocally, the probe was
incubated with NEx from MRC5 cells alone (lane 6) or
complemented with rU2AF65 (lane 7). rU2AF65 was required
for shifting the mobility of the complex and the remaining probe,
in a different manner than rU2AF65 alone (lane 8).
(PDF)
Figure S5 Transfection of the cDNA for tREST into
MRC5 cells modifies RRAD and TMS-1 basal expres-
sion. (A) Putative binding sites for REST were localized close to
the TATA box in the promoters of the human RRAD and TMS-1
genes. (B) RT-PCR showing the altered expression of RRAD and
TMS-1 in cells transfected with the tREST cDNA (lane 2),
compared to the MOCK transfections (lane 3), and no RT
controls (lane 1). The GA3PDH amplicon was used for loading
control.
(PDF)
Figure S6 cREST is readily degraded in H69 cells. (A)
Western blots from emetine-treated (+; 100 mg/mL) or untreated (-
) H69 (upper panel) and MRC5 cells (lower panel). Incubation
times were 1, 5 and 10 h. Canonical (cREST) and truncated
(tREST) isoforms are indicated. (B) Nuclear extracts from H69
cells treated (+) or not (-; 0.2% DMSO only) with the proteasome
inhibitor MG132 at 10 mM final concentration during 4 h were
probed with anti-REST antibody. REST (arrowhead in lane 1)
and ubiquitinated-REST (brackets in lane 2) are shown.
(PDF)
Figure S7 hnRNP H from H69 cells is able to bind to all
G codes. (A) Twenty fmole of a 32P-labeled RNA probe (shown
on top) containing part of the N4-5ss only, the 3’ss, the Py and part
of the upstream intron were incubated with 5 mg of each NEx
from MRC5, A549 (other SCLC cell line) or H69 cells. The
EMSA complexes were resolved in a 4% native polyacrylamide
gel. Proteins from 20 complexes were purified and visualized in
silver stained 10% SDS-polyacrylamide gels. Black arrows show
the proteins that were differentially purified from NEx. (B) A
sample of the purified complexes was electrophoresed and probed
with anti-hnRNP H antibodies by western blot. A strong signal for
hnRNP H was detected in MRC5 (lane 1) and H69 (lane 3) cells
indicating that hnRNP H is recruited to the G1. A less intense
hnRNP H signal was observed in A549 NEx. (C) Two different
RNA probes (drawings at the bottom), with or without the G1
element, were labeled (lanes 1 and 5, respectively) and used in
EMSA with H69 NEx. Both probes rendered complexes with the
NEx (lanes 2 and 6) but that with the G1 element was supershifted
more efficiently with the anti-hnRNP H antibodies (lane 3) as
compared with the modest supershift obtained with the probe
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lacking the G1 element (lanes 7 and 8; antibody added before or
after the probe). Antibodies against hnRNP A did not supershifted
the complexes formed with either probe.
(PDF)
Figure S8 Depletion of U1 snRNA or U2AF65 of H69 NEx
inhibits complex recruiting around the N exon. The wild
type probe (lane 1) was used in EMSA with NEx from H69 cells
(lane 4), or with H69 NEx depleted of U2AF65 (DU2AF65; lane 5)
or with NEx in which the 5’ end of U1 snRNA was degraded by
RNase H-mediated digestion with a complementary oligonucle-
otide (NEx U1 k.o.; lane 3). Complex formation was not
diminished when the U1 snRNA was degraded with a scrambled
oligonucleotide as a control (NEx c.o.; lane 2) and was partially
recovered when the DU2AF65 extracts were supplemented with
recombinant U2AF65 (D65 + rU2AF65; lane 6).
(PDF)
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